Dice Therapeutics Inc DICE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EDT
20.39UNCH (UNCH)
Volume
3,153
Close
20.39quote price arrow up+0.84 (+4.30%)
Volume
305,859
52 week range
12.63 - 40.50
Loading...
  • Open20.03
  • Day High21.33
  • Day Low19.78
  • Prev Close19.55
  • 52 Week High40.50
  • 52 Week High Date09/17/21
  • 52 Week Low12.63
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap779.51M
  • Shares Out38.23M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-19.44

KEY STATS

  • Open20.03
  • Day High21.33
  • Day Low19.78
  • Prev Close19.55
  • 52 Week High40.50
  • 52 Week High Date09/17/21
  • 52 Week Low12.63
  • 52 Week Low Date06/16/22
  • Market Cap779.51M
  • Shares Out38.23M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-19.44

RATIOS/PROFITABILITY

  • EPS (TTM)-1.56
  • P/E (TTM)-13.09
  • Fwd P/E (NTM)-11.20
  • EBITDA (TTM)-57.743M
  • ROE (TTM)-
  • Revenue (TTM)1.13M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-5,287.47%
  • Debt To Equity (MRQ)0.82%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Dice Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
DICE Therapeutics, Inc., formerly Dice Molecules Holdings LLC, is a biopharmaceutical company. The Company leverages its technology platform to build a pipeline of oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. It is focused on developing oral therapeutics against targets in immunology. The Company’s platform, which it refers to as DELSCAPE, is designed to discover selective oral small molecules with the potential to modulate...
Address
279 E. Grand Avenue, Suite 300, Lobby B
South San Francisco, CA
94080
United States